APLLTD.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 May 2024 @ 05:59):

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations...

Stats
Today's Volume	86 219.00
Average Volume	142 717
Market Cap	189.72B
EPS	INR0 ( 2024-05-08 )
Next earnings date	( INR6.90 ) 2024-08-01
Last Dividend	INR8.00 ( 2023-07-28 )
Next Dividend	INR0 ( N/A )
P/E	32.16
ATR14	INR1.238 (0.13%)

Volume Correlation

Long: -0.08 (neutral)

Short: -0.78 (moderate negative)

Signal:(50.111) Neutral

Alembic Pharmaceuticals Correlation

10 Most Positive Correlations
KRITIKA.NS	0.931
ICICIPHARM.NS	0.93
KOPRAN.NS	0.929
NAVNETEDUL.NS	0.923
MUTHOOTFIN.NS	0.921
STAR.NS	0.919
FAIRCHEMOR.NS	0.912
KCP.NS	0.908
AARTISURF.NS	0.907
20MICRONS.NS	0.907

10 Most Negative Correlations
LTGILTBEES.NS	-0.938
4THDIM.NS	-0.936
RAJRILTD.NS	-0.93
JSL.NS	-0.893
ACI.NS	-0.864
GNA.NS	-0.858
SYMPHONY.NS	-0.853
ISMTLTD.NS	-0.849
DFMFOODS.NS	-0.834
GTNIND.NS	-0.817

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alembic Pharmaceuticals Correlation - Currency/Commodity

-0.47
( neutral )

0.31
( neutral )

0.08
( neutral )

0.20
( neutral )

-0.54
( weak negative )

-0.88
( strong negative )

Alembic Pharmaceuticals Financials

Annual	2023
Revenue:	INR62.29B
Gross Profit:	INR27.95B (44.87 %)
EPS:	INR31.33

FY	2023
Revenue:	INR62.29B
Gross Profit:	INR27.95B (44.87 %)
EPS:	INR31.33

FY	2022
Revenue:	INR56.53B
Gross Profit:	INR39.44B (69.77 %)
EPS:	INR17.40

FY	2022
Revenue:	INR52.32B
Gross Profit:	INR35.09B (67.06 %)
EPS:	INR26.50

Financial Reports:

No articles found.

Alembic Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Alembic Pharmaceuticals Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.86 - good (98.56%) | Divividend Growth Potential Score: 3.76 - Decrease likely (24.84%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.400	2012-07-31
Last Dividend	INR8.00	2023-07-28
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	INR62.90	--
Avg. Dividend % Per Year	0.84%	--
Score	3	--
Div. Sustainability Score	9.86
Div.Growth Potential Score	3.76
Div. Directional Score	6.81	--

Next Divdend (Est)
(2024-06-27)

INR8.06 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.00

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR4.00	0.79%
2019	INR5.50	0.94%
2020	INR3.00	0.55%
2021	INR14.00	1.34%
2022	INR10.00	1.24%
2023	INR8.00	1.41%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SOUTHBANK.NS	Dividend Junior	2023-08-17	Sporadic	25	0.42%
MOLDTECH.NS	Dividend Knight	2023-09-18	Annually	9	1.62%
HDFCAMC.NS	Dividend Knight	2023-06-09	Annually	6	1.13%
BHAGERIA.NS	Dividend Junior	2023-09-01	Annually	9	0.93%
RAMCOCEM.NS	Dividend Junior	2023-08-02	Annually	23	0.21%
KIRLOSIND.NS	Dividend Junior	2023-08-03	Annually	17	0.72%
EMUDHRA.NS	Dividend Knight	2023-06-22	Annually	3	0.21%
AKSHARCHEM.NS	No Dividend Player	2023-09-20	Annually	7	0.34%
SWARAJENG.NS	Dividend Knight	2023-07-06	Annually	23	2.81%
NDRAUTO.NS	Dividend Junior	2023-07-12	Annually	4	0.59%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0989	1.500	8.02	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0955	1.200	6.82	8.18	[0 - 0.3]
returnOnEquityTTM	0.136	1.500	9.60	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.12	0.800	4.42	3.54	[1 - 3]
quickRatioTTM	0.810	0.800	9.94	7.95	[0.8 - 2.5]
cashRatioTTM	0.0870	1.500	-0.628	-0.942	[0.2 - 2]
debtRatioTTM	0.0796	-1.500	8.67	-10.00	[0 - 0.6]
interestCoverageTTM	11.98	1.000	6.67	6.67	[3 - 30]
operatingCashFlowPerShareTTM	28.22	2.00	0.595	1.189	[0 - 30]
freeCashFlowPerShareTTM	28.22	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.107	-1.500	9.57	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.649	1.000	2.52	2.52	[0.2 - 0.8]
operatingProfitMarginTTM	0.108	1.000	9.84	9.84	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.081	1.000	5.11	5.11	[0.2 - 2]
assetTurnoverTTM	0.966	0.800	6.89	5.51	[0.5 - 2]
Total Score				9.86

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	31.12	1.000	6.96	0	[1 - 100]
returnOnEquityTTM	0.136	2.50	9.74	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	28.22	2.00	0.595	10.00	[0 - 30]
dividendYielPercentageTTM	0.820	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	28.22	2.00	0.595	1.189	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.148	1.500	5.68	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0890	1.000	-0.274	0	[0.1 - 0.5]
Total Score				3.76

Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.